APA

Hammitzsch A., Tallant C., Fedorov O., O'Mahony A., Brennan P. E., Hay D. A., Martinez F. O., Al-Mossawi M. H., de Wit J., Vecellio M., Wells C., Wordsworth P., Müller S., Knapp S. & Bowness P. (20151230). CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Hammitzsch Ariane, Tallant Cynthia, Fedorov Oleg, O'Mahony Alison, Brennan Paul E, Hay Duncan A, Martinez Fernando O, Al-Mossawi M Hussein, de Wit Jelle, Vecellio Matteo, Wells Christopher, Wordsworth Paul, Müller Susanne, Knapp Stefan and Bowness Paul. 20151230. CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Hammitzsch A., Tallant C., Fedorov O., O'Mahony A., Brennan P. E., Hay D. A., Martinez F. O., Al-Mossawi M. H., de Wit J., Vecellio M., Wells C., Wordsworth P., Müller S., Knapp S. and Bowness P. (20151230). CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Hammitzsch Ariane, Tallant Cynthia, Fedorov Oleg, O'Mahony Alison, Brennan Paul E, Hay Duncan A, Martinez Fernando O, Al-Mossawi M Hussein, de Wit Jelle, Vecellio Matteo, Wells Christopher, Wordsworth Paul, Müller Susanne, Knapp Stefan and Bowness Paul. CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. : Proceedings of the National Academy of Sciences of the United States of America. 20151230.